Stroke Trial, Recruiting NCT06576466 Sponsor: Fundació d'investigació Sanitària de les Illes Balears Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06576466
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old.
  • People who have recently been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel), between 24 hours and 5 days ago.
  • People whose stroke has caused movement difficulties — such as weakness or balance/coordination problems — that require physical rehabilitation.
  • People who are able to understand and sign a consent form, or who have enough support from others to properly follow the study requirements.

Who may not be able to join:

  • People who had a significant physical disability before their stroke, as measured by a standard disability scale (confirm with trial site).
  • People whose overall health is too unstable or serious to take part in active rehabilitation.
  • People whose stroke has left them unable to walk at all without being physically supported by another person — though using a cane, crutch, or walking frame is allowed.
  • People who have moderate or severe difficulty swallowing, in a way that could make it hard to follow the treatment plan.
  • People who have used creatine supplements or anabolic (muscle-building) products in the last 3 months.
  • People with severe kidney disease, as defined by a specific kidney function measurement (confirm with trial site).
  • People with bone, joint, or muscle conditions — such as fractures, severe joint disease, or tendon injuries — that would prevent muscle strength from being properly assessed.
  • People with a history of allergic reactions to creatine.
  • People who are pregnant or breastfeeding.
  • People who are already taking part in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raquel Delgado Mederos, PhD, Fundació d'investigació Sanitària de les Illes Balears

Phone: 0034971205234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundació d'investigació Sanitària de les Illes Balears
Registry
ClinicalTrials.gov
Start date
27 September 2024
Est. completion
1 February 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Physical performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov